SPRINGWORKS THERAPEUTICS, INC. Revenue
SPRINGWORKS THERAPEUTICS, INC. reported Revenue of $191.59 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2025-02-20
- SPRINGWORKS THERAPEUTICS, INC. revenues for the quarter ending 2024-12-31 was $61.55M, a 1029.96% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. revenues for the quarter ending 2024-09-30 was $49.30M.
- SPRINGWORKS THERAPEUTICS, INC. revenues for the quarter ending 2024-06-30 was $59.73M.
- SPRINGWORKS THERAPEUTICS, INC. revenues for the quarter ending 2024-03-31 was $21.01M.
- SPRINGWORKS THERAPEUTICS, INC. revenues for fiscal 2024 was $191.59M, a 3417.33% increase from fiscal 2023.
- SPRINGWORKS THERAPEUTICS, INC. revenues for fiscal 2023 was $5.45M.
- SPRINGWORKS THERAPEUTICS, INC. revenues for fiscal 2022 was $0.00.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2024-12-31 | $61.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $110.85M derived: sum of 2 quarters · filed 2025-02-20 | $170.58M derived: sum of 3 quarters · filed 2025-02-20 | $191.59M 10-K · filed 2025-02-20 |
| 2024-09-30 | $49.30M 10-Q · filed 2024-11-12 | $109.03M derived: sum of 2 quarters · filed 2024-11-12 | $130.04M 10-Q · filed 2024-11-12 | $135.49M derived: sum of 4 quarters · filed 2025-02-20 |
| 2024-06-30 | $59.73M 10-Q · filed 2024-08-07 | $80.74M 10-Q · filed 2024-08-07 | $86.19M derived: sum of 3 quarters · filed 2025-02-20 | $86.19M derived: sum of 4 quarters · filed 2025-02-20 |
| 2024-03-31 | $21.01M derived: 10-K 12 month − 3 quarters · filed 2025-02-20 | $26.45M derived: sum of 2 quarters · filed 2025-02-20 | $26.45M derived: sum of 3 quarters · filed 2025-02-20 | $26.45M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $5.45M derived: sum of 2 quarters · filed 2025-02-20 | $5.45M derived: sum of 3 quarters · filed 2025-02-20 | $5.45M 10-K · filed 2025-02-20 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-20 |